(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1313288 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA CTD PMID:22079256 1,2-dichloroethane increases expression ISO RGD:1313289 6480464 ethylene dichloride results in increased expression of PLXNA2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine decreases expression ISO RGD:1313289 6480464 1, 2-Dimethylhydrazine results in decreased expression of PLXNA2 mRNA CTD PMID:22206623 17beta-estradiol multiple interactions ISO RGD:1313288 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of PLXNA2 mRNA CTD PMID:30165855 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:1313289 6480464 [2 more ... CTD PMID:25510870 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:21394737 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1313289 6480464 2 more ... CTD PMID:24680724 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:1313289 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1313289 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in decreased expression of PLXNA2 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA] CTD PMID:16054899 , PMID:16214954 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLXNA2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA CTD PMID:23238561 more ... 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313289 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1313289 6480464 Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of PLXNA2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1313288 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLXNA2 mRNA CTD PMID:20106945 2,3,7,8-Tetrachlorodibenzofuran decreases expression EXP 6480464 2 more ... CTD PMID:32109520 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of PLXNA2 mRNA CTD PMID:21346803 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:1313289 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of PLXNA2 mRNA CTD PMID:26251327 3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone affects response to substance ISO RGD:1313288 6480464 PLXNA2 gene SNP affects the susceptibility to 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone CTD PMID:25622337 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1313289 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA] CTD PMID:16054899 4,4'-sulfonyldiphenol increases expression ISO RGD:1313289 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PLXNA2 mRNA CTD PMID:30951980 , PMID:33297965 4,4'-sulfonyldiphenol increases methylation ISO RGD:1313288 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of PLXNA2 gene CTD PMID:31601247 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of PLXNA2 mRNA CTD PMID:21346803 4-hydroxyphenyl retinamide increases expression ISO RGD:1313289 6480464 Fenretinide results in increased expression of PLXNA2 mRNA CTD PMID:28973697 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PLXNA2 mRNA CTD PMID:24780913 7,12-dimethyltetraphene decreases expression ISO RGD:1313289 6480464 9 more ... CTD PMID:32553695 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PLXNA2 mRNA CTD PMID:31881176 aflatoxin B1 decreases methylation ISO RGD:1313288 6480464 Aflatoxin B1 results in decreased methylation of PLXNA2 gene CTD PMID:27153756 aflatoxin B1 increases methylation ISO RGD:1313288 6480464 Aflatoxin B1 results in increased methylation of PLXNA2 intron CTD PMID:30157460 Aflatoxin B2 alpha increases methylation ISO RGD:1313288 6480464 aflatoxin B2 results in increased methylation of PLXNA2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1313288 6480464 Tretinoin results in increased expression of PLXNA2 mRNA CTD PMID:21934132 , PMID:23724009 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1313289 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA] CTD PMID:17460151 arsane affects methylation ISO RGD:1313288 6480464 Arsenic affects the methylation of PLXNA2 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1313288 6480464 Arsenic affects the methylation of PLXNA2 gene CTD PMID:25304211 arsenite(3-) increases expression ISO RGD:1313289 6480464 arsenite results in increased expression of PLXNA2 mRNA CTD PMID:33053406 benzo[a]pyrene increases expression ISO RGD:1313289 6480464 Benzo(a)pyrene results in increased expression of PLXNA2 mRNA CTD PMID:21569818 more ... benzo[a]pyrene affects methylation ISO RGD:1313288 6480464 Benzo(a)pyrene affects the methylation of PLXNA2 intron CTD PMID:30157460 benzo[a]pyrene decreases methylation ISO RGD:1313288 6480464 Benzo(a)pyrene results in decreased methylation of PLXNA2 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1313289 6480464 Benzo(a)pyrene metabolite results in decreased expression of PLXNA2 mRNA CTD PMID:32553695 benzo[a]pyrene decreases expression ISO RGD:1313288 6480464 Benzo(a)pyrene results in decreased expression of PLXNA2 mRNA CTD PMID:20106945 more ... benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1313288 6480464 7 more ... CTD PMID:19150397 , PMID:26238291 benzo[b]fluoranthene increases expression ISO RGD:1313289 6480464 benzo(b)fluoranthene results in increased expression of PLXNA2 mRNA CTD PMID:26377693 benzo[e]pyrene increases methylation ISO RGD:1313288 6480464 benzo(e)pyrene results in increased methylation of PLXNA2 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1313289 6480464 Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1313289 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of PLXNA2 mRNA] CTD PMID:19850644 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PLXNA2 mRNA CTD PMID:25181051 , PMID:30816183 bisphenol A decreases methylation ISO RGD:1313288 6480464 bisphenol A results in decreased methylation of PLXNA2 gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:1313288 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene CTD PMID:31601247 bisphenol A increases expression ISO RGD:1313288 6480464 bisphenol A analog results in increased expression of PLXNA2 mRNA CTD PMID:32387340 bisphenol A increases expression ISO RGD:1313289 6480464 bisphenol A results in increased expression of PLXNA2 mRNA CTD PMID:30245210 , PMID:35479511 bisphenol F increases expression ISO RGD:1313289 6480464 bisphenol F results in increased expression of PLXNA2 mRNA CTD PMID:30951980 bromobenzene decreases expression EXP 6480464 bromobenzene results in decreased expression of PLXNA2 mRNA CTD PMID:32479839 buspirone decreases expression EXP 6480464 Buspirone results in decreased expression of PLXNA2 mRNA CTD PMID:24136188 buta-1,3-diene increases expression ISO RGD:1313289 6480464 1, 3-butadiene results in increased expression of PLXNA2 mRNA CTD PMID:29038090 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of PLXNA2 mRNA CTD PMID:19167457 calcitriol increases expression ISO RGD:1313288 6480464 Calcitriol results in increased expression of PLXNA2 mRNA CTD PMID:16002434 carbamazepine affects expression ISO RGD:1313288 6480464 Carbamazepine affects the expression of PLXNA2 mRNA CTD PMID:25979313 carbon nanotube affects expression ISO RGD:1313289 6480464 Nanotubes, Carbon affects the expression of PLXNA2 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1313289 6480464 Nanotubes, Carbon analog results in increased expression of PLXNA2 mRNA CTD PMID:25554681 carbon nanotube decreases expression ISO RGD:1313289 6480464 Nanotubes, Carbon analog results in decreased expression of PLXNA2 mRNA CTD PMID:25620056 CGP 52608 multiple interactions ISO RGD:1313288 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLXNA2 gene] CTD PMID:28238834 chloroprene increases expression ISO RGD:1313289 6480464 Chloroprene results in increased expression of PLXNA2 mRNA CTD PMID:23125180 ciguatoxin CTX1B affects expression ISO RGD:1313289 6480464 Ciguatoxins affects the expression of PLXNA2 mRNA CTD PMID:18353800 cisplatin decreases expression ISO RGD:1313288 6480464 Cisplatin results in decreased expression of PLXNA2 mRNA CTD PMID:27392435 cisplatin multiple interactions ISO RGD:1313288 6480464 [Cisplatin co-treated with jinfukang] results in decreased expression of PLXNA2 mRNA CTD PMID:27392435 clobetasol decreases expression ISO RGD:1313289 6480464 Clobetasol results in decreased expression of PLXNA2 mRNA CTD PMID:27462272 cobalt dichloride decreases expression ISO RGD:1313288 6480464 cobaltous chloride results in decreased expression of PLXNA2 mRNA CTD PMID:19320972 copper(II) sulfate increases expression ISO RGD:1313288 6480464 Copper Sulfate results in increased expression of PLXNA2 mRNA CTD PMID:19549813 cyclosporin A increases expression ISO RGD:1313288 6480464 Cyclosporine results in increased expression of PLXNA2 mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A decreases methylation ISO RGD:1313288 6480464 Cyclosporine results in decreased methylation of PLXNA2 promoter CTD PMID:27989131 cyclosporin A decreases expression ISO RGD:1313288 6480464 Cyclosporine results in decreased expression of PLXNA2 mRNA CTD PMID:27989131 dexamethasone multiple interactions ISO RGD:1313289 6480464 [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA, Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PLXNA2 mRNA] CTD PMID:16054899 dorsomorphin multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin affects expression ISO RGD:1313288 6480464 Doxorubicin affects the expression of PLXNA2 mRNA CTD PMID:25529476 doxorubicin increases expression ISO RGD:1313288 6480464 Doxorubicin results in increased expression of PLXNA2 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PLXNA2 mRNA CTD PMID:29391264 epoxiconazole affects expression ISO RGD:1313289 6480464 epoxiconazole affects the expression of PLXNA2 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1313289 6480464 Ethanol results in increased expression of PLXNA2 mRNA CTD PMID:30319688 ethanol affects splicing ISO RGD:1313289 6480464 Ethanol affects the splicing of PLXNA2 mRNA CTD PMID:30319688 ferroheme b increases expression ISO RGD:1313289 6480464 Heme metabolite results in increased expression of PLXNA2 mRNA CTD PMID:19191707 folic acid decreases expression ISO RGD:1313289 6480464 Folic Acid results in decreased expression of PLXNA2 mRNA CTD PMID:25629700 fulvestrant multiple interactions ISO RGD:1313288 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of PLXNA2 gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of PLXNA2 mRNA CTD PMID:26194646 geldanamycin increases expression ISO RGD:1313288 6480464 geldanamycin results in increased expression of PLXNA2 mRNA CTD PMID:26705709 genistein increases expression ISO RGD:1313289 6480464 Genistein results in increased expression of PLXNA2 mRNA CTD PMID:32186404 glafenine increases expression EXP 6480464 Glafenine results in increased expression of PLXNA2 mRNA CTD PMID:24136188 heme b increases expression ISO RGD:1313289 6480464 Heme metabolite results in increased expression of PLXNA2 mRNA CTD PMID:19191707 hydrogen cyanide increases expression ISO RGD:1313289 6480464 Hydrogen Cyanide results in increased expression of PLXNA2 mRNA CTD PMID:33914522 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of PLXNA2 mRNA CTD PMID:20080153 methapyrilene increases methylation ISO RGD:1313288 6480464 Methapyrilene results in increased methylation of PLXNA2 intron CTD PMID:30157460 methotrexate affects expression ISO RGD:1313289 6480464 Methotrexate affects the expression of PLXNA2 mRNA CTD PMID:18502557 N-methyl-4-phenylpyridinium decreases expression ISO RGD:1313288 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of PLXNA2 mRNA CTD PMID:24810058 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of PLXNA2 mRNA CTD PMID:24136188 nickel sulfate decreases expression ISO RGD:1313288 6480464 nickel sulfate results in decreased expression of PLXNA2 mRNA CTD PMID:22714537 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PLXNA2 mRNA CTD PMID:24136188 oxaliplatin decreases expression ISO RGD:1313289 6480464 Oxaliplatin results in decreased expression of PLXNA2 protein CTD PMID:30031110 ozone multiple interactions ISO RGD:1313289 6480464 pyrazolanthrone inhibits the reaction [Ozone results in increased expression of PLXNA2 mRNA] CTD PMID:17460151 panobinostat multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA CTD PMID:27188386 panobinostat increases expression ISO RGD:1313288 6480464 panobinostat results in increased expression of PLXNA2 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1313289 6480464 Acetaminophen affects the expression of PLXNA2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PLXNA2 mRNA CTD PMID:33387578 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLXNA2 mRNA CTD PMID:32479839 paracetamol increases expression ISO RGD:1313288 6480464 Acetaminophen results in increased expression of PLXNA2 mRNA CTD PMID:29067470 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of PLXNA2 mRNA CTD PMID:32680482 PCB138 multiple interactions ISO RGD:1313289 6480464 [2 more ... CTD PMID:25510870 phenobarbital decreases expression ISO RGD:1313289 6480464 Phenobarbital results in decreased expression of PLXNA2 mRNA CTD PMID:19270015 , PMID:23091169 phenylmercury acetate increases expression ISO RGD:1313288 6480464 Phenylmercuric Acetate results in increased expression of PLXNA2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA CTD PMID:27188386 potassium chromate multiple interactions ISO RGD:1313288 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of PLXNA2 mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:1313288 6480464 potassium chromate(VI) results in decreased expression of PLXNA2 mRNA CTD PMID:22079256 potassium cyanide increases expression ISO RGD:1313289 6480464 Potassium Cyanide results in increased expression of PLXNA2 mRNA CTD PMID:33914522 potassium dichromate increases expression ISO RGD:1313289 6480464 Potassium Dichromate results in increased expression of PLXNA2 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1313289 6480464 Pregnenolone Carbonitrile results in decreased expression of PLXNA2 mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:1313289 6480464 propiconazole results in decreased expression of PLXNA2 mRNA CTD PMID:21278054 resveratrol multiple interactions ISO RGD:1313289 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA] CTD PMID:31298478 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PLXNA2 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1313288 6480464 Silicon Dioxide analog results in decreased expression of PLXNA2 mRNA CTD PMID:25895662 silver atom increases expression ISO RGD:1313289 6480464 Silver results in increased expression of PLXNA2 mRNA CTD PMID:27131904 silver(0) increases expression ISO RGD:1313289 6480464 Silver results in increased expression of PLXNA2 mRNA CTD PMID:27131904 sodium arsenite decreases expression ISO RGD:1313288 6480464 sodium arsenite results in decreased expression of PLXNA2 mRNA CTD PMID:22714537 sotorasib multiple interactions ISO RGD:1313288 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA CTD PMID:36139627 tert-butyl hydroperoxide increases expression ISO RGD:1313288 6480464 tert-Butylhydroperoxide results in increased expression of PLXNA2 mRNA CTD PMID:15336504 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:1313289 6480464 Carbon Tetrachloride results in decreased expression of PLXNA2 mRNA CTD PMID:31919559 tetrachloromethane increases expression ISO RGD:1313289 6480464 Carbon Tetrachloride results in increased expression of PLXNA2 mRNA CTD PMID:29987408 tetraphene decreases expression ISO RGD:1313289 6480464 benz(a)anthracene results in decreased expression of PLXNA2 mRNA CTD PMID:26377693 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PLXNA2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1313289 6480464 titanium dioxide results in increased expression of PLXNA2 mRNA CTD PMID:27760801 , PMID:31298478 titanium dioxide multiple interactions ISO RGD:1313289 6480464 Resveratrol inhibits the reaction [titanium dioxide results in increased expression of PLXNA2 mRNA] CTD PMID:31298478 trametinib multiple interactions ISO RGD:1313288 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of PLXNA2 mRNA CTD PMID:36139627 trichostatin A increases expression ISO RGD:1313288 6480464 trichostatin A results in increased expression of PLXNA2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA CTD PMID:27188386 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of PLXNA2 mRNA CTD PMID:30589522 triptonide increases expression ISO RGD:1313289 6480464 triptonide results in increased expression of PLXNA2 mRNA CTD PMID:33045310 tris(2-butoxyethyl) phosphate affects expression ISO RGD:1313288 6480464 tris(2-butoxyethyl) phosphate affects the expression of PLXNA2 mRNA CTD PMID:29024780 troglitazone decreases expression ISO RGD:1313289 6480464 troglitazone results in decreased expression of PLXNA2 mRNA CTD PMID:28973697 urethane increases expression ISO RGD:1313288 6480464 Urethane results in increased expression of PLXNA2 mRNA CTD PMID:28818685 valdecoxib decreases expression EXP 6480464 valdecoxib results in decreased expression of PLXNA2 mRNA CTD PMID:24136188 valproic acid decreases methylation ISO RGD:1313288 6480464 Valproic Acid results in decreased methylation of PLXNA2 gene CTD PMID:29154799 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of PLXNA2 mRNA CTD PMID:29427782 valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of PLXNA2 mRNA CTD PMID:29427782 valproic acid affects expression ISO RGD:1313288 6480464 Valproic Acid affects the expression of PLXNA2 mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1313288 6480464 Valproic Acid results in increased expression of PLXNA2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO RGD:1313288 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLXNA2 mRNA CTD PMID:27188386 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PLXNA2 mRNA CTD PMID:30207508
